Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
-
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
-
89bio Provides Business Update and Outlook for 2025
-
ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
-
Extendicare Announces Timing of 2024 Fourth Quarter Results and Conference Call
-
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th
-
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
-
Vital Farms on Track to Deliver Strong Growth in 2025 with Key Investments in Resilient Supply Chain and Farm Network Expansion
-
Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update
-
Apollo to Acquire Argo Infrastructure Partners
-
Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities
-
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
-
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
-
NANO Nuclear Energy Closes Acquisition of Patented Micro Modular Reactor (MMR®) and Pylon Transportable Reactor Technologies
-
Telesat Announces Key Executive Leadership Changes
-
Tactile Medical Appoints Laura King to Board of Directors
-
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
-
Prodeon Medical Announces Enrollment Completion for Expander-2 Pivotal Trial
-
BigCommerce Empowers Easy, Flexible Ecommerce with Catalyst One-Click Storefront Launch
-
Sunlight Solutions Unveils Innovative Updates: Streamlined UI, AI Enhancements, and Global Features
-
Kratos Receives New Hypersonic System Program Award with Total Potential Value of Approximately $100 Million
-
Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025
-
FOREWARN to Provide Identity Verification Services to Greater Baltimore Board of REALTORS® to Promote Agent Safety
-
Wondr Health Expands Interventions to Address and Prevent High-Cost Chronic Conditions
-
ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
-
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
-
COMSTOCK RESOURCES, INC. ANNOUNCES FOURTH QUARTER 2024 EARNINGS DATE AND CONFERENCE CALL INFORMATION
-
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2024
-
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
The RoyaLand Company Ltd. to Deliver a Live Investor Presentation via the Skyline Signature Series™
-
VEON to List Kyivstar on Nasdaq in New York, Signs Letter of Intent with Cohen Circle
-
ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
genXtraits Inc. and Solis Agrosciences enter collaboration agreement
-
VivoPower’s Caret Digital Secures CAD$140m Definitive Binding Investment Commitment from Global Alternative Investment Group, GEM Global Yield LLC SCS
-
MCI Study: Brain Exercises Drive Cognitive and Functional Gains in Pre-Dementia Patients
-
Arcadia Enables Healthcare Providers to Deliver Precision Medicine at Scale
-
Act III Holdings Announces Strategic Investment in Honest Greens Barcelona
-
DTE Energy spends $3.3 billion with Michigan suppliers in 2024
-
Celestica Q4 2024 Financial Results and Conference Call Thursday, January 30, 2025
-
Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium
-
Lifeward Cancels Its Extraordinary General Meeting of Shareholders
-
Wearable Devices Gains Global Recognition at CES 2025 for Innovation in Neural Gesture-Control Technology
-
Rock Samples Return Grades up to 0.51% copper (Cu) from the Rayfield Copper-Gold Property, South-Central British Columbia
-
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
-
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
-
Amalgamated Financial Corp. Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2024 Update
-
Rio2 Provides Fenix Gold Mine Construction Update
-
Traxys and HNK Alpha Execute First Nickel Sulphate Futures Block Trade on Abaxx Commodity Futures Exchange and Clearinghouse
